LINSPEC NEW

Registration number: GOV-60 

Dosage form: Injectable solution 

Composition: Each 10 ml contains:

Spectinomycin dihydrochloride pentahydrate: 1 g

Lincomycin hydrochloride: 0.5 g

Excipients q.s: 10 ml

Indications: 

LINSPEC NEW is indicated for the treatment of various respiratory and digestive diseases in dogs and cats, including tonsillitis, conjunctivitis, bronchitis, laryngitis, pneumonia, abscesses, osteomyelitis, gingivitis, arthritis, dermatitis, diarrhea, fever, vomiting, anorexia, infected wounds, and soft tissue infections.

Dosage and administration:

Administer by intramuscular or subcutaneous injection: 1 ml/5 kg body weight.

Use continuously for 3-5 days.

Withdrawal period: None. 

Storage: Store in a dry, cool place, away from direct sunlight, at a temperature not exceeding 30°C.

FOR VETERINARY USE ONLY.